StemCell Institute Inc.TSE 7096

株式会社ステムセル研究所 · Pharmaceutical · FY ends Mar

Share price at FY-end
¥766
FY ending Mar 2026
Market cap at FY-end
¥7.8B
Dividend per share
—
Avg. director pay
¥50.0M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 Japan Trim Co., Ltd. 7,174,200 71.24% ¥5.5B —
2 Nagoya Small and Medium Enterprise Investment and Development Co., Ltd. 168,000 1.67% ¥129M —
3 山本 邦松 90,200 0.90% ¥69.1M —
4 Supercell Biotechnology Corporation 70,000 0.70% ¥53.6M —
5 ステムセル研究所従業員持株会 65,989 0.66% ¥50.5M —
6 若松 茂美 51,800 0.51% ¥39.7M —
7 清水 崇文 51,400 0.51% ¥39.4M —
8 楽天証券株式会社 46,200 0.46% ¥35.4M —
9 仲 博之 42,900 0.43% ¥32.9M —
10 尾林 雅夫 32,400 0.32% ¥24.8M —

Officers' holdings and pay

NameTitleSharesValuePay
清水 崇文 President & Representative Director 51,400 ¥39.4M —
山田 智男 Director 1,000 ¥765,800 —
安藤 公秀 Director 4,000 ¥3.1M —
大久 保由美 Director — — —
長江 賢 Full-time Audit & Supervisory Board Member — — —
藤川 義人 Audit & Supervisory Board Member — — —
森澤 夕子 Audit & Supervisory Board Member 30,000 ¥23.0M —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Mar 2026 ¥766 ¥15.44 49.6x — 10,246,600
FY ending Mar 2025 ¥1,356 ¥37.67 36.0x ¥25.0 10,246,600
FY ending Mar 2024 ¥1,979 ¥30.35 65.2x — 10,246,600
FY ending Mar 2023 ¥2,515 ¥19.33 130.1x — 10,246,600
FY ending Mar 2022 ¥4,017 ¥26.41 152.1x — 5,123,300
FY ending Mar 2021 — ¥12.81 — — 4,867,100
Source: annual securities reports on EDINET. Values are estimates. Methodology